Medibio Provides Update on FDA Process Sydney, Australia and Minneapolis, MN USA – 9 November 2018: Medibio Limited (MEB or the Company) (ASX: MEB) (OTCQB: MDBIF), a mental health technology company, today provides an update regarding the current De Novo [...]
Medibio Appoints Global Healthcare & Medical Device Leader as CEO and Managing Director Sydney, Australia and Minneapolis, MN USA – 2 November 2018: Medibio Limited (MEB or the Company)(ASX: MEB)(OTCQB: MDBIF), a mental health technology company, announces the [...]
Sydney, Australia and Minneapolis, MN USA – 8 October 2018: Medibio Limited (MEB or the Company)(ASX: MEB)(OTCQB: MDBIF), a mental health technology company, is happy to announce that two clinical abstracts by Dr. Archie Defillo et al. have been [...]
Sydney, Australia and Minneapolis, MN USA – 3 October 2018: Medibio Limited (MEB or the Company)(ASX: MEB)(OTCQB: MDBIF), a mental health technology company, today announced the release of ilumen™, its product and platform for corporate customers. ilumen™ is a [...]
The awards are the longest-standing business awards program in Australia, identifying and acknowledging the achievements of Australia’s best business operators. October 1, 2018 | By Medibio Team Sydney, Australia and Minneapolis, MN USA – Oct. 01, 2018: Medibio Limited [...]
Medibio Announces Executive Leadership Changes Sydney, Australia and Minneapolis, MN USA – 21 September 2018: The Board of Medibio Limited (MEB or the Company)(ASX: MEB)(OTCQB: MDBIF), today announced several changes to the Company’s executive leadership team. Medibio is pleased [...]
Medibio releases transcript from September 11, 2018 call responding to investors' questions about recently released clinical study results. View Transcript
September 11, 2018 | By Terry Cornick --- “Switching off” is not binary for everyone in a workplace situation. Some of us work in a typical structured environment, a regimented 9-5 and get our allotted lunch breaks. Some of [...]
Medibio Clinical Study Shows Over 20% Improvement to Current Diagnostic Standard September 6, 2018 | By Medibio Team Highlights: - Global 230 patient (8 sites) study confirms Medibio’s Depression Diagnostic Aide (DX04) - With 70% accuracy, 70% sensitivity [...]
September 5, 2018 | By Medibio Team Medibio today announced that Lindsey Hagan has joined the company as VP of Integrated Health Systems. As VP of the Integrated Health Systems business unit, Hagan will partner with the company’s technology [...]
